Lusay, Rodellaze Dan M.
HRN: 22-56-35 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2025
CEFUROXIME 750MG (VIAL)
09/23/2025
09/30/2025
IV
380 Mg
Q 8 Hours
PCAP-C
Checking Initial Appropriateness